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The treatment of inoperable lung tumors is af-
fected by respiration and it is challenging to treat 
with high dose hypo-fractionated radiosurgery 
[1]. Radiosurgery is the preferred treatment op-
tion for non-small cell lung cancer [2]. With the 
advent of newer technology, there has been a rap-
id increase in the use of lung radiosurgery for 
both early-stage lung cancer and lung metastases 
[3]. An integrated, effective motion management 
technique is necessary to treat moving targets. 
There are several treatment machines, such as ro-
botic radiosurgery systems (Cyberknife, Accuray, 
Sunnyvale, USA) or a linac, utilizing intensity‐
modulated radiotherapy (IMRT) or volumetric‐
modulated arc therapy (VMAT) which can deliver 
the desired radiation dose incorporating motion 
management. In the absence of an integrated mo-
tion compensation technique, tumor motion has 
to be taken into account by adding an individual 
safety margin (internal margin) around the CT 
AbstrAct
background: The advances in image guidance and capability of highly conformal dose deliveries made possible the use of 
helical tomotherapy (hT) for lung cancer treatment. To determine the effect of respiratory motion on the delivered dose in 
hT, film dosimetry using a dynamic phantom was performed. This was a phantom study to determine the effect of motion on 
the delivered dose in hT.
Materials and methods: 4D computed tomography (4DcT) was acquired for various target motions of cIrs dynamic phan-
tom (cIrs Inc., Norfolk, Usa) with 2.5cm diameter spherical target of volume 8.2 cc moving in the cOs4 motion pattern. aveIp 
images and treatment plans were generated in the hT planning system. Target excursions during treatment delivery were 
changed in the superior-inferior, anteroposterior and lateral directions. The breathing cycle time was varied from 4 to 5 sec. 
and also the delivery interruptions were introduced. a film was exposed for each delivery and gamma analysis was performed. 
results: The gamma pass rate (Gpr) with 3%, 2 mm criteria for the target motion in the s-I direction showed a significant 
reduction from 97.5% to 54.4% as the motion increased from 3 mm to  8 mm (p = 0.03). For the target motion in s-I = 8 mm, 
L-r = a-p = 3 mm, the percentage decrease in the Gpr was 74% (p = 0.001) for three interruptions.
conclusion: The ITV based approach in hT is ideal for a shallow breathing situation when the tumor excursions were confined 
to 5 mm in the s-I and 3 mm in L-r and a-p directions.
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visualized clinical target volume (CTV) [4]. This 
can be incorporated by four-dimensional (4D) CT 
simulation and treatment planning to customize 
the margins. Maximum intensity projection (MIP) 
and average intensity projection (AveIP) are cre-
ated from 4D CT Simulation data which is a series 
of three-dimensional (3D) CT image sets acquired 
at all the respiratory phases and sorted into differ-
ent phases of the respiratory cycle. The detailed 
knowledge of tumour motion captured in the 4D 
CT is used to delineate motion encompassing tar-
get volumes, such as internal target volume (ITV) 
from MIP or AveIP image sets for the treatment 
planning [5–7]. The use of ITV for respiratory 
motion increases the target volume resulting in 
additional healthy tissue irradiation. Recently, 
helical tomotherapy (HT) has been explored for 
treating moving targets [8–11]. Gated delivery al-
lows treatment of planning target volume (PTV) 
in a selected portion of the breathing waveform, 
between specified time intervals, or specified am-
plitudes, thus reducing the size of clinical and 
planning target volumes (CTV and PTV) by as-
sessing the extent of target motion over one respi-
ratory cycle. The continuous movement of the pa-
tient couch during the treatment delivery makes it 
difficult to implement gated delivery in HT. In the 
recent version of HT, such as Radixact (Accuray 
Incorporated, Sunnyvale, CA), real-time motion 
correction by tracking the moving target, with-
out interrupting treatment delivery is compatible 
[12]. However, in the absence of such a modern 
technique, for moving tumors such as lung, the 
ITV based treatment is well accepted in conven-
tional Linacs. For VMAT delivery using FF and 
FFF beams, ITV based treatment plans are a safe 
and efficient way of delivering the dose [13–15]. 
Various strategies, such as ITV from MIP or AveIP 
images, and mid position strategies (MidIP) have 
successfully been implemented in HT for lung 
tumors [8–14, 16]. But the HT treatment is de-
livered with continuously translating the patient 
couch through the gantry while the entire linear 
accelerator mounted on the gantry rotates around 
the target. Hence, the interplay between the ma-
chine dynamics and the target motion may lead to 
artifacts in the dose distribution [17]. Further, it 
has been shown that the target motion can change 
from day to day and even during treatment due 
to change in the breathing pattern making the 
ITV based treatment plans inadequate for target 
coverage [18].
Several studies assessed the dose coverage and 
the target motion during HT delivery. But all these 
studies are limited to one-dimensional target mo-
tion [19–21]. Hence, the study was extended incor-
porating the target motion in all the 3 dimensions. 
For this, a study was designed to determine the 
differences in the delivered dose to the planned 
dose for target motion in 3 dimensions, includ-
ing the superior-inferior (S-I), left-right (L-R), and 
anterior-posterior (A-P) directions. Further, in the 
current version of the HT delivery system, upon 
any beam interruption, the couch must be repo-
sitioned to its initial position when the beam is 
resumed. This will add up the chances of intra-frac-
tion motion variability resulting in dose delivery er-
ror. Hence, a comprehensive study was performed 
to find the effect of treatment interruptions on the 
dose delivery when the target is in 3-dimensional 
motion.
This is a dosimetric study on a dynamic phantom 
was performed to determine the effect of target mo-
tion in the S-I, A-P, and L-R directions. The effect 
of change in the breathing cycle and the effect of 
treatment interruptions on the dose delivery when 
the target is in 3-dimensional motion was studied.
Materials and methods
Dynamic Thorax phantom  
with moving target
In this study, a Dynamic Thorax Phantom model 
008A (CIRS, Norfolk, VA) with CIRS motion con-
trol software (version 2.4.0) was used for treatment 
plan and delivery. This phantom contains a 2.5 cm 
diameter spherical target of volume 8.2 cc placed 
inside the lung volume. The CIRS phantom was set 
to perform a regular Cos(4) breathing model since 
the Cos(4) breathing model approximates the real-
istic patient breathing cycles with a non-constant 
amplitude and periodicity [19]. The target was pro-
grammed for an amplitude of 0 mm to ± 15 mm 
covering ± 3, ± 5, ± 8, ± 10, ± 12, and 15mm ampli-
tudes in the S-I direction about their corresponding 
reference positions with a speed of 4 seconds per 
cycle. In addition to the programmed S-I motion, 
simultaneous motions in the A-P and L-R direc-
tions were programmed from ± 0 mm, ± 3 mm, 
and ± 5 mm amplitudes.
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A cork inserts of 6.4 cm diameter with a polysty-
rene film holder, which accommodates a Gafchro-
mic EBT3 cut film of the size 6 cm × 4 cm in the 
sagittal plane, was indigenously designed for the 
plan verification. 4D CT images of the CIRS phan-
tom with the cork inserts were acquired for all the 
motion dynamics as mentioned earlier and AveIP 
imagers were reconstructed. Delivery quality assur-
ance plans were created using these AveIP images 
for all the 28 treatment plans. In these plans, the 
CIRS phantom was placed so that the film would 
pass through the PTV to ensure that the dose dis-
tribution would be measured in this region.
cT simulation and treatment planning
Cine CT images of 0.625 mm slice thickness were 
acquired with the tube current of 200 mA, and volt-
age of 120 KVp at Optima 580W CT Scanner (GE 
Medical Systems, Chicago, USA). 4D CT images 
were acquired using Smart Deviceless 4D feature 
from GE Medical Systems (Chicago, USA) for all the 
target excursions. The scan time at each table posi-
tion was set to ensure that the scan covers the entire 
respiratory cycle per table position. Maximum In-
tensity Projection (MIP) and average intensity pro-
jection (AveIP) images from 10 phase binned image 
sets were generated using the D4D algorithm (GE 
Medical Systems, Chicago, USA). 36 simulations 
were performed for various motion combination 
amplitudes ranging from (0, 0, 0) to (15, 5, 5) in the 
[S-I, L-R, A-P] directions and CT images were ac-
quired. The MIP and AveIP images were exported to 
the Precision Treatment planning system (Accuray, 
Sunnyvale, USA) and the ITV delineation was done 
with a consistent window width of 600 and window 
level of 40. An isotropic margin of 5 mm was added 
to ITV to generate PTV for treatment planning.
The treatment plans were generated for all the 
motion combination CT images as per the plan set-
ting parameter and optimization goals in Table 1. 
The dose prescription was set to 6.5 Gy for 95% of 
the PTV.
Treatment delivery
The DQA plans were run on the tomotherapy 
unit with Cos(4) motion for all the motion combi-
nations in the [S-I, L-R, A-P] directions mentioned 
earlier. Also, the target motion ranging from 0 mm 
to 15 mm in S-I, 0 mm to 5 mm in A-P, and 0 mm 
to 5mm in the L-R direction with an increment of 
3 mm was introduced during delivery. The combi-
nation of target motion in simulation and delivery 
are shown in the Table 2. A total of 1260 treatment 
deliveries (35 each for one simulated motion) cov-
ering the intended motion up to 15mm in the S-I 
direction and 5 mm in the A-P and L-R directions 
were performed. During the treatment delivery, 
a Gafchromic EBT3 film of 6 cm × 4 cm size was 
table 1. Universal plan and optimization parameter
Delivery mode helical




prescription 6.5 Gy in 1 fraction
table 2. The target motion in s-I, L-r and a-p directions during simulation and treatment delivery
Target motion dimension in mm
S-I direction L-R direction A-P direction
Simulation Treatment Simulation Treatment Simulation Treatment
0 0 to 15 0 0 0 0
0 0 0 to 5 0 to 5 0 0
0 0 0 0 0 to 5 0 to 5
3 0 to 15 3 0 to 5 3 0 to 5
5 0 to 15 3 0 to 5 3 0 to 5
8 0 to 15 3 0 to 5 3 0 to 5
10 0 to 15 3 0 to 5 3 0 to 5
12 0 to 15 3 0 to 5 3 0 to 5
15 0 to 15 3 0 to 5 3 0 to 5
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sandwiched tightly in a polystyrene film holder in 
the sagittal plane and placed in the cork insert as 
shown in Figure 1. 
Delivery interruptions
For the target motion combination of [S-I, L-R, 
A-P], where S-I is ranging from 0 mm to 15 mm, 
L-R and A-P are ranging from 0 mm to 5 mm, the 
treatment delivery was interrupted for 1–3 times and 
treatment completion procedure was created and de-
livered. For each interruption, the patient couch was 
repositioned to the initial position and the partial 
fraction was delivered as per the completion proce-
dure protocol of the Radixct delivery system. 
Dosimetric evaluation
The exposed Gafchromic EBT3 film was scanned 
on Epson 10000XL Scanner after 24 hours of ir-
radiation. Film pixel values were converted to dose 
using a calibration curve developed in SNC Patient 
software (version 8.2, Sun Nuclear Corporation, 
Melbourne, USA) compared to the sagittal dose 
map calculated by Precision treatment planning 
software. The dose in the film was compared with 
the planned dose using SNC Patient software. All 
the comparisons were conducted using absolute 
dose values. The comparison of the isodose distri-
bution was performed by gamma analysis with the 
criteria of DD/DTA (i.e. DD — dose difference and 
DTA — distance to agreement), 3%/2 mm with 
10% low dose threshold. The % of gamma pass rate 
(GPR) was computed with the absolute dose dif-
ference normalized to the global maximum dose 
and the relative DTA. In general, the 2D GPR cri-
terion of 3%/3 has been commonly recommended 
for a conventional IMRT machine; hence, a stricter 
tolerance is recommended for stereotactic body ra-
diation (SBRT) treatment [22]. Therefore, the 3%/2 
mm criterion is usually used as a more restrictive 
GPR criterion with a 10% low dose threshold. The 
central-axis dose profiles along the film axis, as well 
as the gamma analysis results, were plotted and an-
alyzed. The statistical analysis was performed using 
SPSS software ver. 21.0 (IBM, Armonk, NY, USA), 
and the statistical significance was set at p < 0.05 
using student two-tailed paired t-test. 
results
Target motion in s-I direction  
during simulation
The GPR from the delivery sets of various target 
motion for S-I simulated treatment plans is shown 
in Figure 2. In this case, the target motion was 
confined to the S-I direction during the simula-
tion. During the treatment delivery, the target mo-
tion amplitudes were varied in the S-I direction as 
shown in Table 2. It is found from Figure 2, that the 
GPR is significantly reduced as the motion in the 
S-I direction increases beyond 8 mm (p = 0.03). 
Further, when simultaneous motion in A -P and 
L-R is included, the gamma is reduced further be-
yond 3mm of amplitude.
Target motion in a-p direction  
during simulation
The GPR from the delivery sets of various target 
motion for A-P simulated treatment plans is shown 
Figure 1. sagittal plane polystyrene film holder for 
Gafchromic eBT3 film with the cork insert designed for 
Dynamic Thorax phantom model 008a (cIrs, Norfolk, Va)
Figure 2. Gamma pass rate (Gpr) for planned Vs delivery, 
when the target motion was in the s-I direction.  
The values in the parenthesis are the planned motion  
in the s-I, L-r, and a -p directions during the simulation.  























                  95% gamma pass
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in Figure 3. In this case, the target motion was 
confined to the A-P direction during the simula-
tion. During the treatment delivery, the target mo-
tion amplitudes were varied in the A-P direction 
as shown in Table 2. It is found from Figure 3, that 
the GPR was significantly reduced as the motion in 
the A-P direction increased beyond 3 mm during 
delivery for a simulated motion of 1 mm (p = 0.02). 
For a simulated A-P motion of 3 mm or more, the 
GPR was above 95% for the delivery motions rang-
ing from 0 mm to 5 mm.
Target motion in L-r direction  
during simulation
The GPR from the delivery sets of various target 
motion for L-R simulated treatment plans is shown 
in Figure 4. In this case, the target motion was con-
fined to the L-R direction during the simulation. 
During the treatment delivery, the target motion 
amplitudes were varied in the L-R directions as 
shown in Table 2. It is found from Figure 4, that the 
GPR is significantly reduced as the motion in the 
L-R direction shifts beyond 2 mm from the simu-
lated motion (p = 0.20). For a treatment plan simu-
lated with the target motion of (0, 1, 0), the delivery 
beyond (0, 3, 0) adding 2 mm additional motion 
in the L-R directions, reduces the GPR from 96% 
to 94%. When the L-R motion was increased to 5 
mm, the GPR decreased further to 92%. For a plan 
of (0, 5, 0), the GPR was reduced from 97.5% to 
92.5% when the motion was reduced to (0, 0, 0). 
The change in the GPR was not significant when 
the simulated motion of 3 mm in the L-R direction 
increased to 5 mm during delivery (p = 0.158).
simultaneous target motion in s-I, L-r, 
and a-p direction during simulation
The simultaneous target motion of 3,5,8, and 10 
in S-I direction and 3 and 5 mm in L-R and A-P 
directions were applied during simulation. The 
treatments were delivered by varying the (S-I, L -R, 
A-P) dimensions from (0, 0, 0) to (15, 5, 5) mm as 
shown in Table 2. The GPR from the delivery sets 
of various target motion for simultaneous target 
motion simulated treatment plans are shown in 
Figure 5 and 6. It is found from Figure 5, that the 
GPR reduces below 94.5 % as the motion increases 
above 2 mm of the simulated motion of (3, 3, 3). 
For a simulated plan with the motion of (10, 3, 3), 
the gamma reduced to 67% when the motion was 
increased to (10, 5, 5) during delivery. Similarly, 
for a simulated target motion of (5, 5, 5), the deliv-
ery beyond (5, 3, 3) reduced the GPR below 95% 
(p = 0.001) (Fig. 6).
effect of breathing cycles  
during delivery
The target motion during the simulation was 
kept as (3, 0, 0), (3, 3, 3), (5, 0, 0), (8, 0, 0), (8, 3, 3) 
and (10, 0, 0). The breathing cycle was kept at 4 sec-
onds per cycle during the simulation. During the 
treatment delivery, the breathing cycle was varied 
to 5 secs per cycle. 
Figure 3. Gamma pass rate (Gpr) for planned Vs delivery, 
when the target motion was in the a-p direction.  
The values in the parenthesis are the planned motion  
in the s-I, L-r, and a -p directions during the simulation.  






















              95% gamma values
Figure 4. Gamma pass rate (Gpr) for planned Vs delivery, 
when the target motion was in the L-r direction.  
The values in the parenthesis are the planned motion  
in the s-I, L-r, and a -p directions during the simulation.  
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The breathing cycle time did not influence the 
GPR up to the target motion of (5, 0, 0). When the 
target motion was increased to 8 mm in the S-I 
direction, the GPR was decreased from 95.1% to 
82.5 % (p = 0.006) for 4-sec to 5-sec breathing cycle 
(Fig. 7).
Delivery interruptions
In this case, the delivery was interrupted up to 3 
times during the treatment. The original delivery 
without interruption was compared with the one, 
two, and three interruptions. From Figure 8, the 
interruptions did not influence the GPR up to the 
5 mm motion in the S-I direction. When the S-I 
motion was increased to 5 mm, with the A-P and 
L-R motion of 3 mm applied simultaneously, the 
GPR decreased from 95% to 74% (p = 0.001) for 3 
interruptions. 
Discussions
The present work focused on the delivery ac-
curacy in tomotherapy in the presence of target 



















Motion amplitude during delivery in (S-L, L-R, A-P) directions
 Planned (3,5,5) Planned (5,5,5) Planned (8,5,5) Planned (10,5,5)
Figure 5. Gamma pass rate (Gpr) for planned Vs delivery, when the target motion was in the s -I, L-r, and a-p directions. 
The values in the parenthesis are the planned motion in the s-I, L-r, and a -p directions during the simulation.  
The simultaneous motion of 3 mm on L-r and a-p was applied with the s-I motion ranging from 0 mm to 10 mm during  
the simulation. During the treatment delivery, simultaneous motion ranging from 0 mm 5 mm in the L-r and a-p directions 



















Motion amplitude during delivery in (S-L, L-R, A-P) directions
 Planned (3,5,5) Planned (5,5,5) Planned (8,5,5) Planned (10,5,5)
Figure 6. Gamma pass rate (Gpr) for planned Vs delivery, when the target motion was in the s -I, L-r, and a-p direction. 
The values in the parenthesis are the planned motion in the s-I, L-r, and a -p directions during the simulation.  
The simultaneous motion of 5 mm on L-r and a-p was applied with the s-I motion ranging from 0 mm to 10 mm during 
the simulation. During the treatment delivery, simultaneous motion ranging from 0 mm 5 mm in the L-r and a-p direction 
with the s-I motion ranging from 0 mm to 15 mm was applied
Figure 7. Gamma pass rate (Gpr) in % for planned 
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Motion amplitude
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study, the treatment accuracy by gamma analysis 
was studied using a film when the target is sub-
jected to various motion during simulation and 
treatment.  It was necessary to study the treatment 
accuracy during helical delivery of the treatment 
and apply an appropriate strategy for the moving 
targets in tomotherapy delivery. This study assumed 
that there would be a good correlation between 
the simulation and treatment delivery for moving 
targets. Also, this correlation would be consistent 
over the entire course of the treatment when the 
treatment was delivered for different tumor motion, 
breathing cycle, and treatment interruptions. This 
was achieved with the help of the CIRS dynamic 
phantom with target motion in known dimensions. 
The gamma passing systematically showed lower 
values for the moving target when the target mo-
tion was increased by more than 3 mm in the S-I 
and 3 mm in A-P and L-R directions. This could 
be due to the limitation of the helical delivery as 
the tumor motion takes a larger amplitude, and the 
chances of missing the intended target dose due to 
the phase mismatch between couch positions in the 
Z-direction and the gantry rotation with the target 
motion as shown in the Figure 9. 
The difference in the GPR with the planned dose 
increased for longer breathing cycle time. The dif-
ference was significant for the combination of mo-
tion above (8, 0, 0) in (S-I, L -R, A-P) directions. 
As the cycle time increased, for a target motion up 
to 5 mm in the S-I direction, the increase in the 


























 (3,0,0) (3,3,3) (5,0,0) (8,0,0) (8,3,3) (10,0,0)
Motion amplitude
No interruption First interruption Second interruption Third interruption
Figure 8. Gamma pass rate (Gpr) in % for planned Vs delivery for 0, 1, 2, and 3 interruptions during treatment delivery
Figure 9. The dose profile comparison between the planned (black) and delivered dose (magenta) on a moving phantom on 
the central axis of the target in the longitudinal axis. The values in the parenthesis are the target motion during the delivery 
in (s-I, L-r, a-p) direction for a planned target excursion of (5, 0, 0)
 (5,0,0) (5,3,3) (5,5,5) (8,0,0)
 (10,0,0) (10,5,5) (12,0,0) (15,5,5)
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the GPR. This is mainly due to the averaging effect 
of the delivered dose since the target trajectory is 
small. But when the target motion was increased 
to 8 mm in the S-I direction, the delivered dose 
was less than the intended dose. This was evident 
in the GPR. 
The treatment interruptions did not influence 
the delivery accuracy as long as the target motion 
was within (5, 0, 0). When the target motion was 
increased to (5, 3, 3), the GPR decreased signifi-
cantly from 96.5% to 74% for zero interruption 
to 3 interruptions. This decrease is not due to the 
HT machine capability to pick up the treatment 
from the interruption since for a static tumor, the 
interruptions did not decrease the GPR during the 
commissioning of the machine for clinical use. This 
mismatch could be due to the result of a synchro-
nization mismatch between couch translation to 
the target motion. This difference increased as the 
motion in the S-I direction increased as shown in 
Figure 8. 
These observations show that even after gener-
ating a proper ITV from AveIP images using 4D 
CT, the dose coverage to the target is suboptimal 
when the target moves differently than simulation. 
The GPRs were in the acceptable limit when the 
target motion was up to 5 mm in the S-I direction 
with the A-P and L-R motion up to 3 mm. This 
was the case even for the simultaneous motion of 
the target. 
In lung SBRT, the irradiation time has the high-
est influence on the dose coverage. The irradiation 
time in HT strongly depends on the planning pa-
rameters used for the treatment plan preparation 
such as modulation factor, pitch, which is the ratio 
of couch translation per rotation to the field width, 
and field width. Decreasing the modulation factor 
reduces treatment time with reduced plan quality. 
Hence, the modulation factor of 2.0 was fixed at 
all the treatment plans in this study. Further, small 
pitch value introduces leaf time inaccuracies with 
smaller leaf opening times (LOT) [23]. The treat-
ment time was reduced by almost 50% when the 
field width (FW) changed from 2.5 cm to 5 cm but 
at the cost of less optimal dose distribution. And 
also, for a tumor of the size 2.5 cm diameter, the 
use of 5 cm field width is sub-optimal since mo-
tion excursions used in this study for the target in 
the S-I direction was only up to a maximum of 15 
mm. The pitch of 0.287 and modulation factor of 
2.0 were chosen so that the gantry period is main-
tained at 15 seconds to improve treatment accuracy 
by increasing the LOT and, thereby, reducing the 
delivery time. 
conclusion
In a phantom study, when high target motion is 
involved, the ITV based approach is ideal for a shal-
low breathing situation where the tumor excursions 
were confined to 5 mm in the S-I direction and 3 
mm in the L-R and A-P directions. 
If the tumor motion is above 5 mm in the S-I 
direction, a change in the breathing cycle by 1 sec, 
introduced significant error in the delivered dose. 
The influence of delivery interruptions during the 
treatment delivery for a moving target showed 
a significant reduction in the GPR for target excur-
sions of above 5 mm in the S-I and 3 mm in L-R and 
A-P directions when the delivery interruption was 






All data generated and analyzed during this study 
are included in this published article.
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